Moderna to Provide up to 125 Million COVID-19 Vaccine Doses Globally in Early 2021

Only 18% of Moderna COVID Vaccine Trial Participants are Latino, Black, Indigenous People

Biotech Moderna said on Friday that Latino, Black and Indigenous people only made up 18% of their phase three vaccine trials participants.
FDA Scientists Endorse Moderna's COVID-19 Vaccine for Emergency Use

US, Moderna Ink $1.5 Billion Deal on COVID-19 Vaccines

By Dana Cruz
The United States has entered an agreement with drugmaker Moderna for 100 million doses of potential COVID-19 vaccines worth around $1.5 billion, both the company and White House announced on Tuesday.
COVID-19 Vaccine, Coronavirus Vaccine

Will a COVID-19 Vaccine be Ready Before the End of 2020? Here's What Experts Say

By Dani O.
There are currently 36 vaccine candidates in pre-clinical studies or clinical trials across the globe, with 2 major companies in the lead.
Scientists develop a vaccine against the coronavirus disease in Saint Petersburg

Moderna to Start Final Phase of COVID-19 Vaccine Trial. How Safe Is It?

By Dani O.
The third and final phase of the trial will involve over 30,000 participants and is expected to begin in July.
Most Read
  1. Brazil Experiences the Worst Floods in Over 80 Years; At Least 39 Dead
  2. Ecuador Files Lawsuit Vs. Mexico in ICJ Over Granting Asylum to Former VP Jorge Glas
  3. Suspect in Killing Chicago Cop Luis Huesca Arrested in His Apartment
  4. Donald Trump Hush Money Trial: Former Trump Spokesperson Hope Hicks Testifies
  5. 14-Year-Old Wisconsin Student Suspected as Active Shooter Killed by Police
Real Time Analytics